GeneMatrix Inc (109820) — Capital Reinvestment Ratio

Latest as of September 2025: 0.05x

GeneMatrix Inc (109820) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩500.19 Million) in capital expenditures (₩23.65 Million). See how leveraged is GeneMatrix Inc's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

₩500.19 Million
KRW

Capital Expenditures

₩23.65 Million
KRW

Data as of

Sep 2025
Most recent filing

GeneMatrix Inc Capital Reinvestment Ratio (2020–2021)

This chart tracks GeneMatrix Inc's Capital Reinvestment Ratio across 2 annual periods. Check 109820 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for GeneMatrix Inc (2020–2021)

Year-by-year Capital Reinvestment Ratio for GeneMatrix Inc from 2020 to 2021. For live market cap and broader valuation context, see GeneMatrix Inc (109820) market capitalisation.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2021 0.08x ₩3.37 Billion ₩258.22 Million ▼ -5.8%
2020 0.08x ₩4.51 Billion ₩366.56 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow